Martin Kulldorff announced his departure from Harvard University, citing a dismissal for his adherence to truth. Kulldorf has been known for his criticism of COVID-19 lockdowns.
What Happened: On Monday, Kulldorff, previously a professor of medicine, shared his experience and the circumstances leading to his firing in a post on X, formerly Twitter.
“I am no longer a professor of medicine at @Harvard. Here is the story of my Harvard experience until I was fired for clinging to the truth,” Kulldorff wrote while attaching the link to his op-ed on City Journal.
In the op-ed, Kulldorff detailed his perspective on the events that unfolded at Harvard, starting with the university’s decision to switch to online learning ahead of government mandates.
He reflected on the broader impact of such decisions as institutions across the country looked to Harvard as a model during the early stages of the pandemic. Kulldorff highlighted that his stance on Covid lockdowns and his dedication to truth were not aligned with the university’s approach, leading to his eventual dismissal.
Why It Matters: Kulldorf made headlines in October 2020 when he published a paper along with Dr. Jay Bhattacharya of Stanford and Dr. Sunetra Gupta of Oxford that questioned pandemic-induced lockdowns and travel restrictions. The paper, christened as the “Great Barrington Declaration,” called for those in higher-risk groups, including older people, to opt for shielding, while those least in danger should "immediately be allowed to resume life as normal.”
The World Health Organization was among numerous other public health organizations and academicians who criticized the paper for lacking a scientific basis.
Read Next: Millions Of Americans Are Considering A Mass Exodus If Donald Trump Wins Again, Says Report
Image via Wikimedia commons
Engineered by Benzinga Neuro, Edited by Pooja Rajkumari
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
